DVAX vs IRM · rev $277.2M vs P/E 136, rev $3.97B
Dynavax Technologies Corporation (DVAX) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
DVAX currently screens at market cap $1.82B. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the DVAX and IRM stock pages for the full models.
Not investment advice.